ArticleNature machine intelligence2025
Histopathology-based protein multiplex generation using deep learning.
Article in Nature machine intelligence, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed.
- Multimodal FRACTAL-MSI and Image Fusion Improves Detection and Resolution of Biomolecule Imaging.ACS central science · 2026Article
- Cellular architecture and neighborhood-informed virtual spatial tumor profiling from histopathology.Cell · 2026Article
- Spotlight on challenges and novel methods in highly multiplexed tissue imaging-based spatial proteomics.Journal of translational medicine · 2026Review
- Advancing AI for multi-omics and clinical data integration in basic and translational cancer research.Nature reviews. Cancer · 2026Review
- Review
- Review
- Review
- A comprehensive survey of computer vision methods for spatial transcriptomics.Briefings in bioinformatics · 2026Review
- Deep learning-driven recognition of panoramic tumor microenvironment features in H&E sections and its application.Journal for immunotherapy of cancer · 2026Review
- Single-Cell and Spatial Omics: Methods and Applications.MedComm · 2026Review
- Spatial omics and AI for clinically actionable cancer biomarkers.PLoS medicine · 2026Article
- miniMTI: minimal multiplex tissue imaging enhances biomarker expression prediction from histology.Research square · 2026Article
- Dual-mode microfluidic immunostaining device for diagnostic biomarkers detection and tumor microenvironment evaluation.Science advances · 2026Article
- Assessing Knowledge Distillation of a Multi-Emitter Localizing Neural Network for Applications in Stochastic Optical Reconstruction Microscopy.bioRxiv : the preprint server for biology · 2025Article
- Query-driven generative AI synthesizes multi-modal spatial omics from histology.bioRxiv : the preprint server for biology · 2025Article
- Multi-modal image analysis for large-scale cancer tissue studies within IMMUcan.Cell reports methods · 2025Article
- Single-cell multimodal analysis reveals tumor microenvironment predictive of treatment response in non-small cell lung cancer.Science advances · 2025Article
- Histopathology-based protein multiplex generation using deep learning.Nature machine intelligence · 2025Article
Corrections and comments
- Update of
Authors and funding
11 authors.
Funding
Abstract
Multiplexed protein imaging offers valuable insights into interactions between tumours and their surrounding tumour microenvironment, but its widespread use is limited by cost, time and tissue availability. Here we present HistoPlexer, a deep learning framework that generates spatially resolved protein multiplexes directly from standard haematoxylin and eosin (H&E) histopathology images. HistoPlexer jointly predicts multiple tumour and immune markers using a conditional generative adversarial architecture with custom loss functions designed to ensure pixel- and embedding-level similarity while mitigating slice-to-slice variations. A comprehensive evaluation of metastatic melanoma samples demonstrates that HistoPlexer-generated protein maps closely resemble real maps, as validated by expert assessment. They preserve crucial biological relationships by capturing spatial co-localization patterns among proteins. The spatial distribution of immune infiltration from HistoPlexer-generated protein multiplex enables stratification of tumours into immune subtypes. In an independent cohort, integration of HistoPlexer-derived features into predictive models enhances performance in survival prediction and immune subtype classification compared to models using H&E features alone. To assess broader applicability, we benchmarked HistoPlexer on publicly available pixel-aligned datasets from different cancer types. In all settings, HistoPlexer consistently outperformed baseline methods, demonstrating robustness across diverse tissue types and imaging conditions. By enabling whole-slide protein multiplex generation from routine H&E images, HistoPlexer offers a cost- and time-efficient approach to tumour microenvironment characterization with strong potential to advance precision oncology.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.